IndexIQ Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-605,986
Closed -$31.8M 1110
2020
Q3
$31.8M Buy
605,986
+599,455
+9,179% +$24.8M 1.31% 24
2020
Q2
$217K Buy
6,531
+22
+0.3% +$700 0.01% 489
2020
Q1
$177K Buy
+6,509
New +$181K 0.01% 693

IndexIQ Advisors's MNTA Position: Q4 2020 in Review

IndexIQ Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 605,986 shares — an estimated $31.8M sold.

IndexIQ Advisors first reported a position in MNTA in Q1 2020 and held it in 3 quarters. The position peaked at $31.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • IndexIQ Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • IndexIQ Advisors sold 605,986 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $31.8M.
  • IndexIQ Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
  • IndexIQ Advisors's Momenta Pharmaceuticals, Inc. position peaked at $31.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on IndexIQ Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.